Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Feb 6, 2013

30071_dirs_2013-02-06_cd9b1c6b-092e-4be9-ac18-78613721b94c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-02-04

Reporting Person: Douglas Robert Andrew (COO ResMed Inc.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-04 ResMed Common Stock M 7500 $21.025 Acquired 107330 Direct
2013-02-04 ResMed Common Stock S 7500 $44.129 Disposed 99830.588 Direct
2013-02-04 ResMed Common Stock S 500 $44.290 Disposed 99330.588 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-04 ResMed Common Stock Options $21.025 M 7500 Disposed 2014-11-07 ResMed Common Stock (7500) Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F2: This transaction was executed in multiple trades at prices ranging from $44.08 to $44.75. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.